Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd has informed BSE that its Board of Directors will meet on Wednesday, 23 July 2025. The main agenda is to approve and take on record the un-audited financial results for the first quarter ended 30 June 2025. The notice also includes a standard 'any other matter' clause for the Board to discuss additional items as needed. No financial numbers, guidance, or specific business decisions have been disclosed in this filing. The company was formerly known as Sun and Shine Worldwide Limited and is based in Ahmedabad, Gujarat.
This is a routine regulatory intimation with no immediate impact on shareholders. Investors should watch for the actual Q1FY26 results, which will be released after the Board meeting on 23 July 2025, for any meaningful insight into the company's performance.